These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25162895)

  • 1. Pasireotide for postoperative pancreatic fistula.
    Yang F; Jin C; Fu D
    N Engl J Med; 2014 Aug; 371(9):875. PubMed ID: 25162895
    [No Abstract]   [Full Text] [Related]  

  • 2. Pasireotide for postoperative pancreatic fistula.
    Allen PJ
    N Engl J Med; 2014 Aug; 371(9):875-6. PubMed ID: 25162894
    [No Abstract]   [Full Text] [Related]  

  • 3. Pasireotide for prevention of pancreatic leak: Is there light at the end of the tunnel?
    Ramesh H
    Natl Med J India; 2014; 27(5):268-9. PubMed ID: 26037428
    [No Abstract]   [Full Text] [Related]  

  • 4. [Perioperative treatment with pasireotide reduces the rate of postoperative pancreatic fistula].
    Strobel O; Büchler MW
    Chirurg; 2014 Sep; 85(9):823. PubMed ID: 25113091
    [No Abstract]   [Full Text] [Related]  

  • 5. Pasireotide for postoperative pancreatic fistula.
    Allen PJ; Gönen M; Brennan MF; Bucknor AA; Robinson LM; Pappas MM; Carlucci KE; D'Angelica MI; DeMatteo RP; Kingham TP; Fong Y; Jarnagin WR
    N Engl J Med; 2014 May; 370(21):2014-22. PubMed ID: 24849084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after Pancreatectomy with Routine Pasireotide Use.
    Kunstman JW; Goldman DA; Gönen M; Balachandran VP; D'Angelica MI; Kingham TP; Jarnagin WR; Allen PJ
    J Am Coll Surg; 2019 Feb; 228(2):161-170.e2. PubMed ID: 30414453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic pasireotide administration following pancreatic resection reduces cost while improving outcomes.
    Abbott DE; Sutton JM; Jernigan PL; Chang A; Frye P; Shah SA; Schauer DP; Eckman MH; Ahmad SA; Sussman JJ
    J Surg Oncol; 2016 Jun; 113(7):784-8. PubMed ID: 27041733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Hydrocortisone vs Pasireotide on Pancreatic Surgery Complications in Patients With High Risk of Pancreatic Fistula: A Randomized Clinical Trial.
    Tarvainen T; Sirén J; Kokkola A; Sallinen V
    JAMA Surg; 2020 Apr; 155(4):291-298. PubMed ID: 32022887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness comparison of prophylactic octreotide and pasireotide for prevention of fistula after pancreatic surgery.
    Welsch T; Müssle B; Distler M; Knoth H; Weitz J; Häckl D
    Langenbecks Arch Surg; 2016 Nov; 401(7):1027-1035. PubMed ID: 27233242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis of somatostatin analogues in the prevention of postoperative complication after pancreaticoduodenectomy.
    Jin K; Zhou H; Zhang J; Wang W; Sun Y; Ruan C; Hu Z; Wang Y
    Dig Surg; 2015; 32(3):196-207. PubMed ID: 25872003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of complications in pancreatic cancer surgery.
    Berberat PO; Friess H; Kleeff J; Uhl W; Büchler MW
    Dig Surg; 1999; 16(4):327-36. PubMed ID: 10449978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients.
    Kawai M; Tani M; Terasawa H; Ina S; Hirono S; Nishioka R; Miyazawa M; Uchiyama K; Yamaue H
    Ann Surg; 2006 Jul; 244(1):1-7. PubMed ID: 16794381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A novel technique for the closure of the pancreatic remnant using jejunal serosa following distal pancreatectomy].
    Issekutz A; Belágyi T; Romics L; Oláh A
    Magy Seb; 2006 Apr; 59(2):117-21. PubMed ID: 16784035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pasireotide for the prevention of postoperative pancreatic fistula: an open debate.
    Zizzo M; Ugoletti L; Manenti A; Annessi V; Pedrazzoli C
    HPB (Oxford); 2019 Jul; 21(7):930-931. PubMed ID: 30782475
    [No Abstract]   [Full Text] [Related]  

  • 15. Pasireotide for the Prevention of Postoperative Pancreatic Fistula: Time to Curb the Enthusiasm?
    Maggino L; Vollmer CM
    Ann Surg; 2018 May; 267(5):e94-e96. PubMed ID: 28306647
    [No Abstract]   [Full Text] [Related]  

  • 16. Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials.
    Li-Ling J; Irving M
    Br J Surg; 2001 Feb; 88(2):190-9. PubMed ID: 11167865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection.
    Ramos-De la Medina A; Sarr MG
    J Hepatobiliary Pancreat Surg; 2006; 13(3):190-3. PubMed ID: 16708293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pasireotide for the Prevention of Postoperative Pancreatic Fistula: A Debate Not To Close Too Early.
    Zizzo M; Ugoletti L; Zanelli M; De Marco L; Annessi V; Pedrazzoli C
    J Am Coll Surg; 2019 May; 228(5):811. PubMed ID: 30770320
    [No Abstract]   [Full Text] [Related]  

  • 19. Are somatostatin or its synthetic analogues helpful in reducing pancreatic fistula?
    Angst E; Gloor B
    Dig Surg; 2012; 29(6):492-3. PubMed ID: 23392316
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of pancreatic fistula after cephalic duodenopancreatectomy].
    Sauvanet A; Belghiti J
    Ann Chir; 1999; 53(7):612-7. PubMed ID: 10520501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.